Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zinc and depression. An update.

Gabriel Nowak1, Bernadeta Szewczyk, Andrzej Pilc

  • 1Department of Cytobiology and Histochemistry, Collegium Medicum, Jagiellonian University, Medyczna 9, PL 30-688 Kraków, Poland. nowak@if-pan.krakow.pl

Pharmacological Reports : PR
|December 31, 2005
PubMed
Summary

Zinc supplementation shows promise as an effective antidepressant therapy. This study highlights zinc

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clozapine levels in inpatients with schizophrenia are not a predictor of rehospitalization: a naturalistic retrospective study.

Pharmacological reports : PR·2026
Same author

Novel 3-Methoxypropanamide Derivatives as Potential Antiseizure and Antinociceptive Agents: Experimental Evidence from In Vitro and In Vivo Studies.

Journal of medicinal chemistry·2026
Same author

Corrigendum to Combined olfactory bulbectomy and zinc deficiency induce complex neurobiological alterations resistant to classical antidepressant treatments: Insights from proteomic and neurochemical analyses' [Progress in Neuro-Psychopharmacology and Biological Psychiatry 145 (2026) 111643].

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Combined olfactory bulbectomy and zinc deficiency induce complex neurobiological alterations resistant to classical antidepressant treatments: Insights from proteomic and neurochemical analyses.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Chronic 5-HT7R activation drives depressive phenotypes and synaptic dysfunction.

Acta pharmacologica Sinica·2026
Same author

Zinc, copper, and magnesium in premenstrual disorders: a narrative review.

Pharmacological reports : PR·2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Current antidepressants have limitations in efficacy and side effects.
  • Zinc acts as a glutamate/N-methyl-D-aspartate (NMDA) receptor antagonist.
  • Zinc influences brain-derived neurotrophic factor (BDNF) and hippocampal zinc levels.

Purpose of the Study:

  • To investigate the antidepressant-like activity of zinc.
  • To explore the role of zinc homeostasis in depression.
  • To evaluate zinc supplementation as an adjunct antidepressant therapy.

Main Methods:

  • Rodent models of depression were used to assess antidepressant-like activity.
  • Clinical observations of serum zinc levels in depressed patients.
  • A preliminary clinical study on zinc supplementation in antidepressant therapy.

Main Results:

  • Zinc demonstrated antidepressant-like effects in animal models.
  • Hypozincemia was observed in depression and normalized with treatment.
  • Preliminary clinical data suggest benefits of zinc supplementation.

Conclusions:

  • Zinc plays a significant role in depression pathology and treatment.
  • Zinc homeostasis is crucial for mental health.
  • Zinc ion holds potential as a clinical antidepressant agent.

Related Experiment Videos